BioCentury
ARTICLE | Company News

Zafgen names Hatfield CEO

October 11, 2017 12:13 AM UTC

Metabolic disease company Zafgen Inc. (NASDAQ:ZFGN) hired Jeffrey Hatfield as CEO. He replaces Thomas Hughes, who will remain president and become CSO.

Hatfield was CEO of Vitae Pharmaceuticals Inc., which Allergan plc (NYSE:AGN) acquired in 2016 (see BioCentury Extra, Sept. 14, 2016)...